C17 - What Do I Do Now?: Neurologic Consultations in Cancer Patients II

Event Time: Saturday May 4, 2019 9:30 am to 11:30 am
Topic(s): Neuro-oncology
Director(s): Patrick Wen MD, FAAN
Description: Recently there has been significant progress in the treatment of cancer with novel targeted therapies and immunotherapies. These agents can be associated with significant neurologic complications. In addition, there is also increasing recognition of neurologic complications that can occur in cancer patients, including paraneoplastic syndromes. Using cases, faculty will present an overview of the neurologic complications of novel cancer therapies, including immunotherapies, as well as neurologic complications of cancer, including neurologic paraneoplastic disease. This program complements What Do I Do Now?: Neurologic Consultations in Cancer Patients I, but covers independent topics.
Completion Message: Participants should be able to recognize the complications of novel targeted molecular therapies and immunotherapies, including checkpoint inhibitors and CAR-T-cell therapies. They will also recognize and be able to manage neurologic complications of cancer, including paraneoplastic syndromes.
CME Credits: 2
Core Competencies: Patient Care, Medical Knowledge, Practice-Based Learning and Improvement

Ready to register for the 2019 AAN Annual Meeting?

Register Now

Related Courses